Although NRPa-308 represents an interesting hit if tumor cells express both NRPs and their ligands VEGFA/VEGFC, specific drugs targeting NRP1 should be more appropriate if only NRP1/VEGFA is present. Here, VEGFC is linked to neoplasm.